The Week Ahead: Hom...
Health Care: Drugs
United Therapeutics Corporation (UTHR: NASDAQ)
$69.17 0.69 | 1.01%
05/17/13 - 04:00 PM ET
Portfolios with UTHR
- Portfolio NameUser Type
- ProJoel Greenblatt - Gotham Ca...
- ContributorDrugs Facing FDA Approval i...
- UserBender
- ContributorStocks With Big Insider Buy...
- ContributorHot Biotech Stocks Traded b...
- Contributor8 Health Care Stocks Inside...
- ContributorStocks With Big Insider Buy...
- Contributor5 Biotech Stocks for 2012
- Contributor5 Low PEG / Low Beta Stocks
- Contributor13 Biotech Stocks Bought an...
Latest UTHR Headlines from TheStreet
- United Stock Hits New 52-Week High (UTHR) 05.14.13 | 02:05 pm
- Leaders of TheStreet's Drug Approval Contest 05.06.13 | 09:05 am
- United Rises On Unusually High Volume (UTHR) 04.30.13 | 04:04 pm
- United Stock Hits New 52-Week High (UTHR) 04.24.13 | 02:04 pm
- The Next Big Thing In Biotech: Decision Week
03.21.13 | 09:03 am - United Reaches New 52-Week High (UTHR) 03.20.13 | 01:03 pm
- United Reaches New 52-Week High (UTHR) 03.12.13 | 03:03 pm
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Programmed Insider Buying? Yes, at Insmed and United Therapeutics 01.24.13 | 08:01 am
- 5 Stocks Insiders are Buying This Week 12.26.12 | 12:12 pm
Press Releases for UTHR
- United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013 - PR Newswire 04.18.13 | 06:04 am
- United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA - PR Newswire 03.25.13 | 05:03 am
- United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013 - PR Newswire 02.19.13 | 06:02 am
- United Therapeutics Announces FDA Acceptance Of Resubmission Of Oral Treprostinil NDA - PR Newswire 02.14.13 | 06:02 am
- United Therapeutics Announces Additional $420 Million Share Repurchase Program - PR Newswire 02.04.13 | 06:02 am
- United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012 - PR Newswire 10.25.12 | 06:10 am
- United Therapeutics Announces Receipt Of Complete Response Letter For Oral Treprostinil NDA - PR Newswire 10.23.12 | 04:10 pm
- United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension - PR Newswire 09.20.12 | 06:09 am
- United Therapeutics Corporation To Announce Second Quarter 2012 Financial Results Before Market Open On Thursday, July 26, 2012 - PR Newswire 07.19.12 | 06:07 am
- United Therapeutics Announces Additional $100 Million Share Repurchase Program - PR Newswire 06.27.12 | 06:06 am
Partner Headlines for UTHR
- United Therapeutics Holds 10-Week Despite FDA Setback - Investor's Business Daily 04.08.13 | 05:04 pm
- Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy - Seeking Alpha 03.28.13 | 09:03 am
- United Therapeutics Shows Why Buying Early Is Risky - Investor's Business Daily 03.25.13 | 05:03 pm
- Stocks End Lower After Notching Multiyear Highs - Investor's Business Daily 03.25.13 | 04:03 pm
- Stocks Lower In Early Afternoon; United Health Slumps - Investor's Business Daily 03.25.13 | 01:03 pm
- Futures Up On Cyprus Bailout; ARM Holdings, Dell, Apollo Rise - Investor's Business Daily 03.25.13 | 09:03 am
- Here's What To Look For In A 'Going Nowhere' Market - Investor's Business Daily 03.22.13 | 05:03 pm
- United Therapeutics Near Top Of Strong Industry Group - Investor's Business Daily 03.15.13 | 05:03 pm
- Biotech Watch-List: Medicine Co., Alkermes, Celgene - Investor's Business Daily 03.11.13 | 05:03 pm
- Medicines Co. In Buy Area As Medical Stocks Hold Up - Investor's Business Daily 02.28.13 | 05:02 pm
